Sol Gel Technologies Ltd
NASDAQ:SLGL

Watchlist Manager
Sol Gel Technologies Ltd Logo
Sol Gel Technologies Ltd
NASDAQ:SLGL
Watchlist
Price: 0.534 USD 12.4% Market Closed
Market Cap: 14.9m USD
Have any thoughts about
Sol Gel Technologies Ltd?
Write Note

Sol Gel Technologies Ltd
Net Issuance of Common Stock

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Sol Gel Technologies Ltd
Net Issuance of Common Stock Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Issuance of Common Stock CAGR 3Y CAGR 5Y CAGR 10Y
Sol Gel Technologies Ltd
NASDAQ:SLGL
Net Issuance of Common Stock
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Teva Pharmaceutical Industries Ltd
TASE:TEVA
Net Issuance of Common Stock
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
I
InterCure Ltd
TASE:INCR
Net Issuance of Common Stock
â‚Ş0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Mediwound Ltd
NASDAQ:MDWD
Net Issuance of Common Stock
$609k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-39%
S
Seach Medical Group Ltd
TASE:SEMG
Net Issuance of Common Stock
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
R
Rekah Pharmaceutical Industry Ltd
TASE:REKA
Net Issuance of Common Stock
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Sol Gel Technologies Ltd
Glance View

Market Cap
14.9m USD
Industry
Pharmaceuticals

Sol-Gel Technologies Ltd. is a clinical-stage dermatology company, which engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases. The firm is focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The Company’s offers a range of products twins, sirs-t, and vered. The firm is designed its proprietary, silica-based microencapsulation technology platform to enhance the tolerability and stability of topical drugs while maintaining their efficacy. Topical drugs often struggle to balance achieving both high efficacy and high tolerability. Its technology platform entraps active ingredients in an inert, inorganic silica shell, which creates an unnoticeable barrier between the active ingredient and the skin.

SLGL Intrinsic Value
0.721 USD
Undervaluation 26%
Intrinsic Value
Price

See Also

Back to Top